rss
Tob Control 2008;17:177-182 doi:10.1136/tc.2007.022368
  • Research paper

A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand

  1. K Thavorn1,2,
  2. N Chaiyakunapruk1,3,4
  1. 1
    Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
  2. 2
    Department of Health Policy, Management, and Evaluation, University of Toronto, Ontario, Canada
  3. 3
    Setting Priority Using Information on Cost-effectiveness Analysis, Ministry of Public Health, Thailand
  4. 4
    School of Population Health, University of Queensland, Australia
  1. Dr Nathorn Chaiyakunapruk, Department of Pharmacy Practice, Naresuan University, Phitsanulok 65000, Thailand; nui{at}u.washington.edu
  • Received 17 June 2007
  • Accepted 5 February 2008
  • Published Online First 19 February 2008

Abstract

Objective: To estimate the incremental cost-effectiveness ratio of a structured community pharmacist-based smoking cessation programme compared with usual care.

Design: A cost-effectiveness study using a healthcare system perspective

Population: Two simulated cohorts of smokers: male and female aged 40, 50 and 60 years who regularly smoke 10–20 cigarettes per day.

Intervention and comparator: A structured community pharmacist-based smoking cessation (CPSC) programme compared to usual care.

Main outcome measure: Cost per life year gained (LYG) attributable to the smoking cessation programme.

Results: The CPSC programme results in cost savings of 17 503.53 baht (£250; €325; $500) to the health system and life year gains of 0.18 years for men and; costs savings of 21 499.75 baht (£307; €399; $614) and life year gains of 0.24 years for women. A series of sensitivity analyses demonstrate that both cost savings and life year gains are sensitive to variations in the discount rate and the long-term smoking quit rate associated with the intervention.

Conclusion: From the perspective of the health system, the CPSC programme yields cost savings and life year gains. This finding provides important information for health policy decision-makers when determining the magnitude of resources to be allocated to smoking cessation service in community pharmacy.

Footnotes

  • Funding: This study was supported, in part, by a grant from the Thailand Research Fund and Thai Pharmacy Network for Tobacco Control (through the Thai Health Promotion Foundation).

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. tc.2007.022368v1
    2. 17/3/177 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register hereto access the free archive of all BMJ Journals.

Don't forget to sign up for content alertsso you keep up to date with all the articles as they are published.